Predict 1-year major bleeding risk in atrial fibrillation patients on oral anticoagulation. Always paired with CHA₂DS₂-VASc to balance stroke vs bleeding risk.
HAS-BLED Score
0/9
Estimated 1-year major bleeding risk: 0.9%
Recommendation
Low bleeding risk. Anticoagulation is safe — proceed if CHA₂DS₂-VASc indicates it. Re-evaluate score annually.
DoctorScribe surfaces patient BP trends, prescribed NSAIDs/antiplatelets, and INR control history right next to the HAS-BLED score — so you never miss a fixable risk factor.
DoctorScribe auto-runs CHA₂DS₂-VASc and HAS-BLED on every AF patient, flags modifiable bleeding factors like uncontrolled BP and NSAID co-prescription, and tracks TTR for warfarin patients.